2D echo

DIAGNOSTIC_TEST2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Autoimmune LymphoproliferativeCommon Variable ImmunodeficiencyGATA2Immune System DiseasesImmunodeficiencyLymphoproliferative DisordersPrimary T-cell Immunodeficiency Disorders

Phase 2

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

Active, not recruitingNCT03663933

National Cancer Institute (NCI)Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders +2

Start: 2018-09-04End: 2030-04-03Updated: 2026-03-17

Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency

Active, not recruitingNCT05907746

National Cancer Institute (NCI)GATA2, Immunodeficiency

Start: 2023-11-29End: 2028-07-31Updated: 2026-08-11

Related Papers

Frequency, kinetics, and clinical significance of HHV-6 DNAemia after PTCy-based hematopoietic cell transplant

Blood Advances2026-07-17